ILMN vs. CRL
Compare and contrast key facts about Illumina, Inc. (ILMN) and Charles River Laboratories International, Inc. (CRL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ILMN or CRL.
Correlation
The correlation between ILMN and CRL is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ILMN vs. CRL - Performance Comparison
Loading data...
Key characteristics
ILMN:
-0.54
CRL:
-0.68
ILMN:
-0.68
CRL:
-0.86
ILMN:
0.92
CRL:
0.87
ILMN:
-0.30
CRL:
-0.50
ILMN:
-1.02
CRL:
-1.42
ILMN:
25.31%
CRL:
27.52%
ILMN:
43.16%
CRL:
53.84%
ILMN:
-96.14%
CRL:
-78.23%
ILMN:
-83.75%
CRL:
-69.15%
Fundamentals
ILMN:
$13.24B
CRL:
$6.92B
ILMN:
-$6.08
CRL:
-$0.61
ILMN:
0.62
CRL:
0.12
ILMN:
3.05
CRL:
1.72
ILMN:
5.59
CRL:
2.17
ILMN:
$4.34B
CRL:
$4.02B
ILMN:
$2.88B
CRL:
$1.28B
ILMN:
-$465.00M
CRL:
$546.00M
Returns By Period
In the year-to-date period, ILMN achieves a -37.93% return, which is significantly lower than CRL's -23.41% return. Over the past 10 years, ILMN has underperformed CRL with an annualized return of -8.40%, while CRL has yielded a comparatively higher 6.89% annualized return.
ILMN
-37.93%
16.50%
-36.55%
-23.23%
-29.51%
-24.93%
-8.40%
CRL
-23.41%
33.31%
-24.60%
-36.20%
-15.30%
-4.27%
6.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ILMN vs. CRL — Risk-Adjusted Performance Rank
ILMN
CRL
ILMN vs. CRL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Illumina, Inc. (ILMN) and Charles River Laboratories International, Inc. (CRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ILMN vs. CRL - Dividend Comparison
Neither ILMN nor CRL has paid dividends to shareholders.
Drawdowns
ILMN vs. CRL - Drawdown Comparison
The maximum ILMN drawdown since its inception was -96.14%, which is greater than CRL's maximum drawdown of -78.23%. Use the drawdown chart below to compare losses from any high point for ILMN and CRL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ILMN vs. CRL - Volatility Comparison
The current volatility for Illumina, Inc. (ILMN) is 13.47%, while Charles River Laboratories International, Inc. (CRL) has a volatility of 20.01%. This indicates that ILMN experiences smaller price fluctuations and is considered to be less risky than CRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ILMN vs. CRL - Financials Comparison
This section allows you to compare key financial metrics between Illumina, Inc. and Charles River Laboratories International, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ILMN vs. CRL - Profitability Comparison
ILMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a gross profit of 683.00M and revenue of 1.04B. Therefore, the gross margin over that period was 65.6%.
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported a gross profit of 317.73M and revenue of 984.17M. Therefore, the gross margin over that period was 32.3%.
ILMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported an operating income of 164.00M and revenue of 1.04B, resulting in an operating margin of 15.8%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported an operating income of 74.67M and revenue of 984.17M, resulting in an operating margin of 7.6%.
ILMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a net income of 131.00M and revenue of 1.04B, resulting in a net margin of 12.6%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Charles River Laboratories International, Inc. reported a net income of 25.47M and revenue of 984.17M, resulting in a net margin of 2.6%.